Related Experiment Video
Updated: Jan 15, 2026

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
NAT2 rapid acetylator phenotype and increased risk of tuberculosis retreatment: A TB cohort study in Northern
Sukanya Wattanapokayakit1, Waritta Sawaengdee1, Punna Kunhapan1
1Medical Life Sciences Institute, Department of Medical Sciences, Ministry of Public Health, Nonthaburi, Thailand.
Objectives:
N-acetyltransferase 2 (NAT2) acetylator status affects circulating levels of isoniazid (INH). We investigated the association between NAT2 acetylator status and the rate of tuberculosis (TB) retreatment among patients who had previously completed treatment for drug-susceptible TB.
Methods:
We analyzed patients aged ≥18 years with TB who completed standard treatment containing INH in Chiang Rai Province, Thailand (2017-2020). Hospital records were merged using Thailand's Health Data Center system to assess TB retreatment over two years. NAT2 acetylator status was determined from six single nucleotide polymorphisms. Cox proportional hazards models adjusted for age, sex, and ethnicity, with the risk period defined as 60-720 days post-treatment.
Results:
Among 624 patients with tuberculosis in Thailand who completed therapy, 10% of the patients required retreatment within two years. NAT2 rapid acetylators exhibited a 2.00-fold (95% CI: 1.06-3.76) increased risk of retreatment compared with intermediate acetylators.
Conclusion:
The association between NAT2 rapid acetylators and retreatment or treatment failure highlights the potential role of insufficient drug exposure with fixed-dose regimens.
Related Concept Videos
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Phase II Reactions: Acetylation Reactions
The substrates for acetylation are typically drugs or their metabolites with an amino, sulfonamide, or hydrazine functional group. Acetylation can occur at several points in the drug molecule, including primary, secondary, and...

